![Andrew Paul Mercieca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Paul Mercieca
Director/Board Member at
Octant Ltd.
Profile
Andrew Paul Mercieca currently works at Octant Ltd., as Director.
Mr. Mercieca also formerly worked at Strategic Partners A, as Independent Director in 2022 and Autolus Therapeutics Plc, as Chief Accounting Officer & Vice President-Finance.
Mr. Mercieca received his undergraduate degree from the University of Portsmouth.
Andrew Paul Mercieca active positions
| Companies | Position | Start |
|---|---|---|
Octant Ltd. | Director/Board Member | - |
Former positions of Andrew Paul Mercieca
| Companies | Position | End |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Comptroller/Controller/Auditor | 2025-04-02 |
| STRATEGIC PARTNERS A/S | Director/Board Member | 2022-06-28 |
Training of Andrew Paul Mercieca
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Portsmouth
 University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strategic Partners A/S
 Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Octant Ltd. | |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
- Stock Market
- Insiders
- Andrew Paul Mercieca
